Axsome Therapeutics Inc (NAS:AXSM)
$ 90.94 -1.47 (-1.59%) Market Cap: 4.37 Bil Enterprise Value: 4.31 Bil PE Ratio: 0 PB Ratio: 42.30 GF Score: 39/100

Q1 2022 Axsome Therapeutics Inc Earnings Call Transcript

May 02, 2022 / 12:00PM GMT
Release Date Price: $34.04 (+7.21%)
Operator

Good morning, and welcome to the Axsome Therapeutics conference call. (Operator Instructions) As a reminder, today's conference call is being recorded.

I would now like to turn the conference over to your host, Mark Jacobson, Chief Operating Officer at Axsome Therapeutics.

Mark L. Jacobson
Axsome Therapeutics, Inc. - COO & Secretary

This morning, we issued 2 press releases. Our earnings press release providing a corporate update and details of the company's financial results for the first quarter of 2022 and the release relating to the FDA's action on the AXS-07 NDA. These crossed the wire a short time ago and are available on our website at www.axsome.com. During today's call, we will be making certain forward-looking statements. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our investigational agents, our clinical and nonclinical plans, our plans to present or report additional data, the anticipated conduct in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot